Holly Barra is an Analyst at Catalio Capital Management, LP.
Prior to joining Catalio, Holly was an Equity Research Associate at Goldman, Sachs & Co. covering Pharma and Biotech.
Holly earned a B.S. in Chemical and Biomolecular Engineering from the University of Maryland in College Park.